Achieve Life Sciences

-$0.09 (-1.23%) As of 6:24 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACHV and other ETFs, options, and stocks.

About ACHV

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor.

CEO
John A. Bencich
Employees
13
Headquarters
Vancouver, British Columbia
Founded
1991

ACHV Key Statistics

Market Cap
79.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
207.04K
High Today
$7.51
Low Today
$7.22
Open Price
$7.39
Volume
42.03K
52 Week High
$18.26
52 Week Low
$6.85

ACHV Earnings

-$2.47
-$1.65
-$0.82
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure